Saturday, March 13, 2021 9:16:19 AM
What!? Man, did Humanigen pay for that ad?
I think I read that we reported $311K in revenue last year. And the analysts are estimating $500M - $1B in '21?
And stockpiling demand, both in the US and internationally.
I think it's a little misleading to suggest an expectation of "lower growth in the coming years." It will take the remaining 9 months of this year, and all of FY22 to penetrate the Covid (-type) market on a world-wide basis. By that time, we'll be well into commercialization of lenz for what should be a booming CAR-T therapy market. The first patient has already been dosed in the Zuma trial. And the ifab trial has already completed clinical trial enrollment for the treatment of solid tumors.
I see year-over-year aggressive growth, with an absolutely jaw-dropping explosion of growth in the immediate time frame. I don't think we need to worry about a "7.5%" growth rate for some very happy time from now.
MARCH GLADNESS!
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM
VAYK Exited Caribbean Investments for $320,000 Profit • VAYK • Jun 27, 2024 9:00 AM
North Bay Resources Announces Successful Flotation Cell Test at Bishop Gold Mill, Inyo County, California • NBRI • Jun 27, 2024 9:00 AM
Branded Legacy, Inc. and Hemp Emu Announce Strategic Partnership to Enhance CBD Product Manufacturing • BLEG • Jun 27, 2024 8:30 AM
POET Wins "Best Optical AI Solution" in 2024 AI Breakthrough Awards Program • POET • Jun 26, 2024 10:09 AM
HealthLynked Promotes Bill Crupi to Chief Operating Officer • HLYK • Jun 26, 2024 8:00 AM